A case of acute progressive diffuse interstitial lung disease preceding idiopathic multicentric Castleman disease
Sign Up to like & getrecommendations! Published in 2020 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2020.101216
Abstract: It has been considered that idiopathic multicentric Castleman disease often involves pulmonary complications recognized as lymphocytic interstitial pneumonia. On the other hand, recent reports show that the computed tomography often show diffuse interstitial lung disease… read more here.
Keywords: disease; castleman disease; multicentric castleman; idiopathic multicentric ... See more keywords
An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000023291
Abstract: Abstract Background: Interleukin 6 (IL-6) inhibitors are the first-line treatment for idiopathic multicentric Castleman disease (iMCD); however, there is no established treatment for cases that are resistant to IL-6 inhibitors. Although sirolimus, a mammalian target… read more here.
Keywords: castleman disease; idiopathic multicentric; multicentric castleman; open label ... See more keywords
Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Sign Up to like & getrecommendations! Published in 2021 at "Pathology international"
DOI: 10.1111/pin.13185
Abstract: Patients with plasma cell type idiopathic multicentric Castleman disease (PC-iMCD) often show elevated serum IgG4 levels and IgG4-positive cell infiltration in tissues due to overproduction of interleukin-6, and may meet the diagnostic criteria for IgG4-related… read more here.
Keywords: igg4; criteria igg4; disease; idiopathic multicentric ... See more keywords
Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Hematology"
DOI: 10.1177/20406207221082552
Abstract: Human herpes virus-8 (HHV8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder sustained by pro-inflammatory cytokines, including interleukin-6 (IL-6). According to the international evidence-based criteria developed by the Castleman Disease Collaborative Network (CDCN),… read more here.
Keywords: patient; idiopathic multicentric; castleman disease; disease ... See more keywords
Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v8.i20.4922
Abstract: BACKGROUND Human herpes virus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder driven by proinflammatory cytokines, which is still poorly understood. Pulmonary parenchyma lesion is a rare condition in iMCD, which… read more here.
Keywords: imcd; multicentric castleman; castleman disease; idiopathic multicentric ... See more keywords
Concurrence of Marjolin’s Ulcer in the Lower Limb in a Patient with Idiopathic Multicentric Castleman Disease: A Case Report
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58010071
Abstract: Idiopathic multicentric Castleman disease (iMCD) is characterized by the benign proliferation of lymphoid cells in multiple regions. However, the co-occurrence of epithelial malignancy and idiopathic multicentric Castleman disease (iMCD) is rarely reported. Herein, we present… read more here.
Keywords: ulcer; idiopathic multicentric; castleman disease; multicentric castleman ... See more keywords